Zinbryta and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 3 people who take Zinbryta and Methotrexate. Common interactions include abdominal discomfort among females.

The phase IV clinical study analyzes what interactions people who take Zinbryta and Methotrexate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

3 people who take Zinbryta and Methotrexate together, and have interactions are studied.

What is Zinbryta?

Zinbryta has active ingredients of daclizumab. Currently, eHealthMe is studying from 2,381 Zinbryta users.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 571,372 Methotrexate users.

Number of Zinbryta and Methotrexate reports submitted per year:

Common Zinbryta and Methotrexate drug interactions by gender *:

female:

Abdominal discomfort
Amnesia
Dysphonia
Dyspnoea
Dystonia
Fall
Fatigue
Gastrointestinal disorder
General physical health deterioration
Grip strength decreased

male:

n/a

Common Zinbryta and Methotrexate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Abdominal discomfort
Amnesia
Dyspnoea
Dystonia
Fall
Fatigue
Gastrointestinal disorder
General physical health deterioration
Grip strength decreased
Hand deformity

* Approximation only. Some reports may have incomplete information.

Do you take Zinbryta and Methotrexate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .

Related studies

Drug side effects by duration, gender and age:

Zinbryta side effects (2,381 reports)
Methotrexate side effects (571,372 reports)

Common Zinbryta drug interactions:

Zinbryta and Ampyra: 218 reports
Zinbryta and Tecfidera: 164 reports
Zinbryta and Baclofen: 150 reports
Zinbryta and Tysabri: 124 reports
Zinbryta and Vitamin d: 121 reports

Browse interactions between Zinbryta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Methotrexate drug interactions:

Methotrexate and Enbrel: 147,114 reports
Methotrexate and Humira: 136,608 reports
Methotrexate and Prednisone: 125,427 reports
Methotrexate and Folic acid: 66,805 reports
Methotrexate and Remicade: 64,430 reports
Methotrexate and Orencia: 59,421 reports
Methotrexate and Sulfasalazine: 59,101 reports
Methotrexate and Xeljanz: 57,551 reports
Methotrexate and Actemra: 55,684 reports
Methotrexate and Leflunomide: 49,213 reports

Browse interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on daclizumab and methotrexate sodium (the active ingredients of Zinbryta and Methotrexate, respectively), and Zinbryta and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zinbryta and Methotrexate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Jardiance and Feeling Jittery - 13 seconds ago
Nicoderm Cq and Muscle Twitching - 17 seconds ago
Vancomycin Hcl and Dermatitis Bullous - 20 seconds ago
Citalopram Hydrobromide and Mayzent drug interaction - 23 seconds ago
Imodium and Gallstones - 25 seconds ago
Ranitidine and Glimepiride drug interaction - 37 seconds ago
Sovaldi and Multi-Organ Failure - 42 seconds ago
Benzonatate and Dicyclomine Hydrochloride drug interaction - a minute ago
Zolpidem Tartrate and Proctalgia - a minute ago
Amlodipine Besylate and Magnesium Chloride drug interaction - a minute ago